Accueil > Actualité
Actualite financiere : Actualite bourse

AstraZeneca: Berenberg raises target price

( - On Monday, Berenberg announced that it had raised its price target for AstraZeneca shares from 130 pence to 150 pence, indicating a upside potential of around 20% from current levels.

In a note, the analyst explains that he is more optimistic about the laboratory's business, saying that he expects annual sales of $74bn by 2030, equivalent to 11.8 pence more per share.

The broker - which maintains its buy recommendation on the stock - points out that this figure is $6bn below the group's 2030 target of $80bn a year.

Copyright (c) 2024 All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
The information and analyses published by Cercle Finance are intended solely as a decision-making aid for investors. Cercle Finance cannot be held responsible, directly or indirectly, for the use of information and analyses by readers. Uninformed investors are advised to consult a professional advisor before investing. This information does not constitute an invitation to sell or a solicitation to buy.




Qui sommes-nous ? | Nous contacter | FAQ | Mentions légales | RSS | © Copyright 2007 Cercle Finance. Tous droits réservés.